Kwang-huei H. Lin
259 Wen Hwa 1 Road
Taoyuan, TNQ, Taiwan
Taoyuan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 109 publications
Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2.
Journal: Cancer cell
Published: June 04, 2026
Novel function of GTPBP2 in promoting hepatocellular carcinoma progression through inhibition of BTRC-mediated KRAS degradation.
Journal: Cancer cell international
Published: July 02, 2025
HBx mutant-regulated RPL13AP25 mediates suboptimal virological response to entecavir and HCC progression.
Journal: Cancer cell international
Published: March 05, 2025
Enhanced inhibitory effects of mianserin in combination with sorafenib on liver cancer growth through targeting the CCR9-AKT pathway.
Journal: American journal of cancer research
Published: March 02, 2025
Thyroid hormone suppresses cell growth by regulating CDK2 and cyclin E1 expression via Hepsin.
Journal: American journal of cancer research
Published: February 23, 2025
PROTACs as Therapeutic Modalities for Drug Discovery in Castration-Resistant Prostate Cancer.
Journal: Annual review of pharmacology and toxicology
Published: August 08, 2024
RNASE4 promotes malignant progression and chemoresistance in hypoxic glioblastoma via activation of AXL/AKT and NF-κB/cIAPs signaling pathways.
Journal: American journal of cancer research
Published: July 14, 2024
The novel role of LOC344887 in the enhancement of hepatocellular carcinoma progression via modulation of SHP1-regulated STAT3/HMGA2 signaling axis.
Journal: International journal of biological sciences
Published: June 15, 2024
CCL16 is a pro-tumor chemokine that recruits monocytes and macrophages to promote hepatocellular carcinoma progression.
Journal: American journal of cancer research
Published: June 07, 2024
Last Updated: 09/26/2026